Stay updated on Combination Immunotherapy in SCLC Clinical Trial

Sign up to get notified when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immunotherapy in SCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a new related topic 'Small cell lung carcinoma' and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:38:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:54.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing Revision: v3.4.2 in the revision history.
    Difference
    0.1%
    Check dated 2026-03-11T12:20:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Adds sponsor-related institutional names (Moffitt Cancer Center / H. Lee Moffitt Cancer Center and Research Institute) and a 'Helpful Links Provided by' section to the page.
    Difference
    0.2%
    Check dated 2026-03-04T09:28:47.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The sponsor/site names and the 'Helpful Links' section were removed from the page.
    Difference
    0.2%
    Check dated 2026-02-18T04:14:47.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Administrative updates: added Revision v3.4.2 and removed the older funding notice and Revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T01:52:24.000Z thumbnail image

Stay in the know with updates to Combination Immunotherapy in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.